nodes	percent_of_prediction	percent_of_DWPC	metapath
Abacavir—ADK—epilepsy syndrome	0.642	1	CbGaD
Abacavir—UGT1A1—Propofol—epilepsy syndrome	0.11	1	CbGbCtD
Abacavir—ADH6—Fatty Acid Omega Oxidation—CYP2D6—epilepsy syndrome	0.00415	0.0689	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—ATIC—epilepsy syndrome	0.00291	0.0483	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—NT5E—epilepsy syndrome	0.00241	0.04	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—ADSL—epilepsy syndrome	0.00221	0.0366	CbGpPWpGaD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—ABCC2—epilepsy syndrome	0.00154	0.0255	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—ATIC—epilepsy syndrome	0.00146	0.0243	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—UPB1—epilepsy syndrome	0.00146	0.0243	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP2C19—epilepsy syndrome	0.0013	0.0216	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP11A1—epilepsy syndrome	0.0013	0.0215	CbGpPWpGaD
Abacavir—UGT1A1—Porphyrin metabolism—ALAD—epilepsy syndrome	0.00121	0.0201	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—NT5E—epilepsy syndrome	0.00121	0.0201	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—CYP2D6—epilepsy syndrome	0.00117	0.0194	CbGpPWpGaD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—CYP2D6—epilepsy syndrome	0.00114	0.019	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—ADSL—epilepsy syndrome	0.00111	0.0184	CbGpPWpGaD
Abacavir—UGT1A1—Heme degradation—HMOX1—epilepsy syndrome	0.00107	0.0178	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—TXNRD1—epilepsy syndrome	0.000998	0.0166	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—ABCC2—epilepsy syndrome	0.000982	0.0163	CbGpPWpGaD
Abacavir—ADH6—head—epilepsy syndrome	0.000952	0.275	CbGeAlD
Abacavir—ADK—Purine metabolism—CAT—epilepsy syndrome	0.000912	0.0151	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—ABCG2—epilepsy syndrome	0.000835	0.0139	CbGpPWpGaD
Abacavir—ADK—Purine metabolism—GPX1—epilepsy syndrome	0.000825	0.0137	CbGpPWpGaD
Abacavir—UGT1A1—Codeine and Morphine Metabolism—ABCB1—epilepsy syndrome	0.000815	0.0135	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP2C19—epilepsy syndrome	0.000692	0.0115	CbGpPWpGaD
Abacavir—UGT1A1—Irinotecan Pathway—BCHE—epilepsy syndrome	0.000692	0.0115	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP11A1—epilepsy syndrome	0.000688	0.0114	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—CYP2D6—epilepsy syndrome	0.000621	0.0103	CbGpPWpGaD
Abacavir—ADH6—Phase 1 - Functionalization of compounds—POMC—epilepsy syndrome	0.000573	0.00951	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCC2—epilepsy syndrome	0.000507	0.00842	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CA13—epilepsy syndrome	0.000474	0.00786	CbGpPWpGaD
Abacavir—UGT1A1—Porphyrin metabolism—HMOX1—epilepsy syndrome	0.000465	0.00772	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—CAT—epilepsy syndrome	0.000458	0.00761	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—CYP2C19—epilepsy syndrome	0.00042	0.00697	CbGpPWpGaD
Abacavir—ADK—Nucleotide metabolism—GPX1—epilepsy syndrome	0.000414	0.00688	CbGpPWpGaD
Abacavir—ADK—forebrain—epilepsy syndrome	0.000385	0.111	CbGeAlD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUND—epilepsy syndrome	0.000372	0.00617	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PDXK—epilepsy syndrome	0.000359	0.00596	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CERS1—epilepsy syndrome	0.000359	0.00596	CbGpPWpGaD
Abacavir—ADH6—Metabolism—FAR1—epilepsy syndrome	0.000359	0.00596	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ADK—epilepsy syndrome	0.000359	0.00596	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GLUD1—epilepsy syndrome	0.000359	0.00596	CbGpPWpGaD
Abacavir—ADH6—Metabolism—L2HGDH—epilepsy syndrome	0.000359	0.00596	CbGpPWpGaD
Abacavir—ADK—telencephalon—epilepsy syndrome	0.000354	0.102	CbGeAlD
Abacavir—ADH6—Metabolism—NHLRC1—epilepsy syndrome	0.000328	0.00545	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GAMT—epilepsy syndrome	0.000328	0.00545	CbGpPWpGaD
Abacavir—ADH6—Metabolism—EPM2A—epilepsy syndrome	0.000328	0.00545	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PNPO—epilepsy syndrome	0.000328	0.00545	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—KCNAB2—epilepsy syndrome	0.000327	0.00543	CbGpPWpGaD
Abacavir—ADH6—Metabolism—QDPR—epilepsy syndrome	0.000305	0.00507	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CA4—epilepsy syndrome	0.000305	0.00507	CbGpPWpGaD
Abacavir—ADH6—Biological oxidations—POMC—epilepsy syndrome	0.000304	0.00505	CbGpPWpGaD
Abacavir—ADH6—Metabolism—COX3—epilepsy syndrome	0.000287	0.00476	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SLC6A8—epilepsy syndrome	0.000287	0.00476	CbGpPWpGaD
Abacavir—ADK—medulla oblongata—epilepsy syndrome	0.000278	0.0804	CbGeAlD
Abacavir—ADH6—Metabolism—SLCO1A2—epilepsy syndrome	0.000272	0.00452	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PFKL—epilepsy syndrome	0.000272	0.00452	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CACNA2D2—epilepsy syndrome	0.000272	0.00452	CbGpPWpGaD
Abacavir—ADH6—Metabolism—KCNB1—epilepsy syndrome	0.000272	0.00452	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC6A8—epilepsy syndrome	0.000272	0.00452	CbGpPWpGaD
Abacavir—UGT1A1—Constitutive Androstane Receptor Pathway—ABCB1—epilepsy syndrome	0.000269	0.00447	CbGpPWpGaD
Abacavir—ADK—midbrain—epilepsy syndrome	0.000254	0.0735	CbGeAlD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUNB—epilepsy syndrome	0.000253	0.0042	CbGpPWpGaD
Abacavir—ADK—Metabolism—CA13—epilepsy syndrome	0.000253	0.0042	CbGpPWpGaD
Abacavir—ADH6—Metabolism—UPB1—epilepsy syndrome	0.000249	0.00413	CbGpPWpGaD
Abacavir—ADH6—Metabolism—NEU1—epilepsy syndrome	0.000249	0.00413	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ATIC—epilepsy syndrome	0.000249	0.00413	CbGpPWpGaD
Abacavir—ADK—spinal cord—epilepsy syndrome	0.000248	0.0717	CbGeAlD
Abacavir—ADH6—Metabolism—HSD17B4—epilepsy syndrome	0.00024	0.00398	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GBE1—epilepsy syndrome	0.000231	0.00384	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PPP1R3C—epilepsy syndrome	0.000231	0.00384	CbGpPWpGaD
Abacavir—ADK—head—epilepsy syndrome	0.000221	0.0638	CbGeAlD
Abacavir—ADH6—Metabolism—ASAH1—epilepsy syndrome	0.000217	0.00361	CbGpPWpGaD
Abacavir—ADH6—Metabolism—STXBP1—epilepsy syndrome	0.000212	0.00351	CbGpPWpGaD
Abacavir—ADK—nervous system—epilepsy syndrome	0.000209	0.0604	CbGeAlD
Abacavir—ADH6—Metabolism—NT5E—epilepsy syndrome	0.000206	0.00342	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALAD—epilepsy syndrome	0.000206	0.00342	CbGpPWpGaD
Abacavir—ADK—central nervous system—epilepsy syndrome	0.000201	0.0582	CbGeAlD
Abacavir—ADK—cerebellum—epilepsy syndrome	0.000197	0.0569	CbGeAlD
Abacavir—ADH6—Metabolism—CACNA1A—epilepsy syndrome	0.000197	0.00327	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ALDH7A1—epilepsy syndrome	0.000197	0.00327	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—HES1—epilepsy syndrome	0.000196	0.00326	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ST3GAL3—epilepsy syndrome	0.000192	0.0032	CbGpPWpGaD
Abacavir—ADK—Metabolism—CERS1—epilepsy syndrome	0.000192	0.00318	CbGpPWpGaD
Abacavir—ADK—Metabolism—PDXK—epilepsy syndrome	0.000192	0.00318	CbGpPWpGaD
Abacavir—ADK—Metabolism—FAR1—epilepsy syndrome	0.000192	0.00318	CbGpPWpGaD
Abacavir—ADK—Metabolism—GLUD1—epilepsy syndrome	0.000192	0.00318	CbGpPWpGaD
Abacavir—ADK—Metabolism—L2HGDH—epilepsy syndrome	0.000192	0.00318	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ADSL—epilepsy syndrome	0.000189	0.00313	CbGpPWpGaD
Abacavir—ADH6—Metabolism—GLUL—epilepsy syndrome	0.000185	0.00307	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CACNA1D—epilepsy syndrome	0.000182	0.00301	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—TXNRD1—epilepsy syndrome	0.000179	0.00297	CbGpPWpGaD
Abacavir—ADK—Metabolism—GAMT—epilepsy syndrome	0.000175	0.00291	CbGpPWpGaD
Abacavir—ADK—Metabolism—PNPO—epilepsy syndrome	0.000175	0.00291	CbGpPWpGaD
Abacavir—ADK—Metabolism—EPM2A—epilepsy syndrome	0.000175	0.00291	CbGpPWpGaD
Abacavir—ADK—Metabolism—NHLRC1—epilepsy syndrome	0.000175	0.00291	CbGpPWpGaD
Abacavir—ADH6—Metabolism—TXNRD1—epilepsy syndrome	0.00017	0.00282	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AQP1—epilepsy syndrome	0.000165	0.00274	CbGpPWpGaD
Abacavir—ADK—Metabolism—CA4—epilepsy syndrome	0.000163	0.00271	CbGpPWpGaD
Abacavir—ADK—Metabolism—QDPR—epilepsy syndrome	0.000163	0.00271	CbGpPWpGaD
Abacavir—ADK—brain—epilepsy syndrome	0.00016	0.0462	CbGeAlD
Abacavir—ADK—Metabolism—COX3—epilepsy syndrome	0.000153	0.00254	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—ABCC2—epilepsy syndrome	0.000151	0.0025	CbGpPWpGaD
Abacavir—ADH6—Metabolism—KCNJ11—epilepsy syndrome	0.000149	0.00247	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CHRM3—epilepsy syndrome	0.000149	0.00247	CbGpPWpGaD
Abacavir—ADK—Metabolism—SLCO1A2—epilepsy syndrome	0.000145	0.00241	CbGpPWpGaD
Abacavir—ADK—Metabolism—CACNA2D2—epilepsy syndrome	0.000145	0.00241	CbGpPWpGaD
Abacavir—ADK—Metabolism—KCNB1—epilepsy syndrome	0.000145	0.00241	CbGpPWpGaD
Abacavir—ADK—Metabolism—PFKL—epilepsy syndrome	0.000145	0.00241	CbGpPWpGaD
Abacavir—ADK—Metabolism—SLC6A8—epilepsy syndrome	0.000145	0.00241	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SLC6A1—epilepsy syndrome	0.00014	0.00232	CbGpPWpGaD
Abacavir—ADK—Metabolism—NEU1—epilepsy syndrome	0.000133	0.00221	CbGpPWpGaD
Abacavir—ADK—Metabolism—ATIC—epilepsy syndrome	0.000133	0.00221	CbGpPWpGaD
Abacavir—ADK—Metabolism—UPB1—epilepsy syndrome	0.000133	0.00221	CbGpPWpGaD
Abacavir—ADK—Metabolism—HSD17B4—epilepsy syndrome	0.000128	0.00212	CbGpPWpGaD
Abacavir—ADK—Metabolism—GBE1—epilepsy syndrome	0.000124	0.00205	CbGpPWpGaD
Abacavir—ADK—Metabolism—PPP1R3C—epilepsy syndrome	0.000124	0.00205	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ABCG2—epilepsy syndrome	0.000122	0.00202	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP2C19—epilepsy syndrome	0.000118	0.00197	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP11A1—epilepsy syndrome	0.000118	0.00195	CbGpPWpGaD
Abacavir—ADK—Metabolism—ASAH1—epilepsy syndrome	0.000116	0.00193	CbGpPWpGaD
Abacavir—ADK—Metabolism—STXBP1—epilepsy syndrome	0.000113	0.00188	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SLC6A4—epilepsy syndrome	0.000112	0.00186	CbGpPWpGaD
Abacavir—ADK—Metabolism—NT5E—epilepsy syndrome	0.00011	0.00183	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALAD—epilepsy syndrome	0.00011	0.00183	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP2C19—epilepsy syndrome	0.000109	0.00182	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP11A1—epilepsy syndrome	0.000109	0.0018	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP2C19—epilepsy syndrome	0.000108	0.00179	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP11A1—epilepsy syndrome	0.000107	0.00178	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CYP2D6—epilepsy syndrome	0.000106	0.00176	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALDH7A1—epilepsy syndrome	0.000105	0.00174	CbGpPWpGaD
Abacavir—ADK—Metabolism—CACNA1A—epilepsy syndrome	0.000105	0.00174	CbGpPWpGaD
Abacavir—ADK—Metabolism—ST3GAL3—epilepsy syndrome	0.000103	0.00171	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL1B—epilepsy syndrome	0.000102	0.0017	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—SLC2A1—epilepsy syndrome	0.000101	0.00168	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ADRA2A—epilepsy syndrome	0.000101	0.00168	CbGpPWpGaD
Abacavir—ADH6—Metabolism—BCHE—epilepsy syndrome	0.000101	0.00167	CbGpPWpGaD
Abacavir—ADK—Metabolism—ADSL—epilepsy syndrome	0.000101	0.00167	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—epilepsy syndrome	9.93e-05	0.00165	CbGpPWpGaD
Abacavir—ADK—Metabolism—GLUL—epilepsy syndrome	9.87e-05	0.00164	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—CYP2D6—epilepsy syndrome	9.81e-05	0.00163	CbGpPWpGaD
Abacavir—ADK—Metabolism—CACNA1D—epilepsy syndrome	9.69e-05	0.00161	CbGpPWpGaD
Abacavir—UGT1A1—Metapathway biotransformation—CYP2D6—epilepsy syndrome	9.68e-05	0.00161	CbGpPWpGaD
Abacavir—ADH6—Metabolism—SLC2A1—epilepsy syndrome	9.61e-05	0.00159	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—HBEGF—epilepsy syndrome	9.51e-05	0.00158	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PLCB1—epilepsy syndrome	9.5e-05	0.00158	CbGpPWpGaD
Abacavir—ADH6—Metabolism—TH—epilepsy syndrome	9.47e-05	0.00157	CbGpPWpGaD
Abacavir—ADK—Metabolism—TXNRD1—epilepsy syndrome	9.07e-05	0.0015	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—epilepsy syndrome	8.91e-05	0.00148	CbGpPWpGaD
Abacavir—ADK—Metabolism—AQP1—epilepsy syndrome	8.8e-05	0.00146	CbGpPWpGaD
Abacavir—UGT1A1—NRF2 pathway—HMOX1—epilepsy syndrome	8.32e-05	0.00138	CbGpPWpGaD
Abacavir—ADK—Metabolism—KCNJ11—epilepsy syndrome	7.96e-05	0.00132	CbGpPWpGaD
Abacavir—ADK—Metabolism—CHRM3—epilepsy syndrome	7.96e-05	0.00132	CbGpPWpGaD
Abacavir—ADH6—Metabolism—HMOX1—epilepsy syndrome	7.9e-05	0.00131	CbGpPWpGaD
Abacavir—ADH6—Metabolism—CAT—epilepsy syndrome	7.8e-05	0.00129	CbGpPWpGaD
Abacavir—ADH6—Metabolism—ABCB1—epilepsy syndrome	7.58e-05	0.00126	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CA13—epilepsy syndrome	7.48e-05	0.00124	CbGpPWpGaD
Abacavir—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—epilepsy syndrome	7.43e-05	0.00123	CbGpPWpGaD
Abacavir—Hypersensitivity—Phenytoin—epilepsy syndrome	7.22e-05	0.00039	CcSEcCtD
Abacavir—Anaphylactic shock—Valproic Acid—epilepsy syndrome	7.18e-05	0.000388	CcSEcCtD
Abacavir—Oedema—Valproic Acid—epilepsy syndrome	7.18e-05	0.000388	CcSEcCtD
Abacavir—Urticaria—Lamotrigine—epilepsy syndrome	7.18e-05	0.000388	CcSEcCtD
Abacavir—Hypersensitivity—Oxcarbazepine—epilepsy syndrome	7.18e-05	0.000388	CcSEcCtD
Abacavir—Malaise—Pregabalin—epilepsy syndrome	7.17e-05	0.000388	CcSEcCtD
Abacavir—Nausea—Propofol—epilepsy syndrome	7.17e-05	0.000387	CcSEcCtD
Abacavir—Vomiting—Fosphenytoin—epilepsy syndrome	7.16e-05	0.000387	CcSEcCtD
Abacavir—Diarrhoea—Felbamate—epilepsy syndrome	7.15e-05	0.000387	CcSEcCtD
Abacavir—Vertigo—Pregabalin—epilepsy syndrome	7.15e-05	0.000386	CcSEcCtD
Abacavir—Body temperature increased—Lamotrigine—epilepsy syndrome	7.14e-05	0.000386	CcSEcCtD
Abacavir—Abdominal pain—Lamotrigine—epilepsy syndrome	7.14e-05	0.000386	CcSEcCtD
Abacavir—Dizziness—Diazepam—epilepsy syndrome	7.14e-05	0.000386	CcSEcCtD
Abacavir—Infection—Valproic Acid—epilepsy syndrome	7.13e-05	0.000386	CcSEcCtD
Abacavir—Leukopenia—Pregabalin—epilepsy syndrome	7.12e-05	0.000385	CcSEcCtD
Abacavir—Rash—Fosphenytoin—epilepsy syndrome	7.1e-05	0.000384	CcSEcCtD
Abacavir—Dermatitis—Fosphenytoin—epilepsy syndrome	7.09e-05	0.000383	CcSEcCtD
Abacavir—Asthenia—Clonazepam—epilepsy syndrome	7.07e-05	0.000382	CcSEcCtD
Abacavir—ADH6—Metabolism—GPX1—epilepsy syndrome	7.05e-05	0.00117	CbGpPWpGaD
Abacavir—Headache—Fosphenytoin—epilepsy syndrome	7.05e-05	0.000381	CcSEcCtD
Abacavir—Hepatitis—Topiramate—epilepsy syndrome	7.05e-05	0.000381	CcSEcCtD
Abacavir—Nervous system disorder—Valproic Acid—epilepsy syndrome	7.04e-05	0.000381	CcSEcCtD
Abacavir—Thrombocytopenia—Valproic Acid—epilepsy syndrome	7.03e-05	0.00038	CcSEcCtD
Abacavir—Asthenia—Phenytoin—epilepsy syndrome	7.03e-05	0.00038	CcSEcCtD
Abacavir—Nausea—Midazolam—epilepsy syndrome	7.01e-05	0.000379	CcSEcCtD
Abacavir—Diarrhoea—Zonisamide—epilepsy syndrome	7e-05	0.000378	CcSEcCtD
Abacavir—Pharyngitis—Topiramate—epilepsy syndrome	7e-05	0.000378	CcSEcCtD
Abacavir—Asthenia—Oxcarbazepine—epilepsy syndrome	6.99e-05	0.000378	CcSEcCtD
Abacavir—Pruritus—Clonazepam—epilepsy syndrome	6.98e-05	0.000377	CcSEcCtD
Abacavir—Vomiting—Vigabatrin—epilepsy syndrome	6.97e-05	0.000377	CcSEcCtD
Abacavir—Skin disorder—Valproic Acid—epilepsy syndrome	6.97e-05	0.000377	CcSEcCtD
Abacavir—Cough—Pregabalin—epilepsy syndrome	6.94e-05	0.000375	CcSEcCtD
Abacavir—Pruritus—Phenytoin—epilepsy syndrome	6.93e-05	0.000375	CcSEcCtD
Abacavir—Connective tissue disorder—Topiramate—epilepsy syndrome	6.93e-05	0.000374	CcSEcCtD
Abacavir—Nausea—Levetiracetam—epilepsy syndrome	6.93e-05	0.000374	CcSEcCtD
Abacavir—Rash—Vigabatrin—epilepsy syndrome	6.92e-05	0.000374	CcSEcCtD
Abacavir—Dizziness—Felbamate—epilepsy syndrome	6.91e-05	0.000374	CcSEcCtD
Abacavir—Dermatitis—Vigabatrin—epilepsy syndrome	6.91e-05	0.000374	CcSEcCtD
Abacavir—Pruritus—Oxcarbazepine—epilepsy syndrome	6.89e-05	0.000373	CcSEcCtD
Abacavir—Convulsion—Pregabalin—epilepsy syndrome	6.89e-05	0.000372	CcSEcCtD
Abacavir—Hypersensitivity—Carbamazepine—epilepsy syndrome	6.89e-05	0.000372	CcSEcCtD
Abacavir—Headache—Vigabatrin—epilepsy syndrome	6.87e-05	0.000371	CcSEcCtD
Abacavir—Vomiting—Diazepam—epilepsy syndrome	6.87e-05	0.000371	CcSEcCtD
Abacavir—Anorexia—Valproic Acid—epilepsy syndrome	6.84e-05	0.00037	CcSEcCtD
Abacavir—Rash—Diazepam—epilepsy syndrome	6.81e-05	0.000368	CcSEcCtD
Abacavir—Dermatitis—Diazepam—epilepsy syndrome	6.8e-05	0.000368	CcSEcCtD
Abacavir—Myalgia—Pregabalin—epilepsy syndrome	6.77e-05	0.000366	CcSEcCtD
Abacavir—Arthralgia—Pregabalin—epilepsy syndrome	6.77e-05	0.000366	CcSEcCtD
Abacavir—Ill-defined disorder—Gabapentin—epilepsy syndrome	6.77e-05	0.000366	CcSEcCtD
Abacavir—Dizziness—Zonisamide—epilepsy syndrome	6.77e-05	0.000366	CcSEcCtD
Abacavir—Headache—Diazepam—epilepsy syndrome	6.77e-05	0.000366	CcSEcCtD
Abacavir—Anxiety—Pregabalin—epilepsy syndrome	6.75e-05	0.000365	CcSEcCtD
Abacavir—Diarrhoea—Clonazepam—epilepsy syndrome	6.75e-05	0.000365	CcSEcCtD
Abacavir—Anaemia—Gabapentin—epilepsy syndrome	6.74e-05	0.000364	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	6.72e-05	0.000363	CcSEcCtD
Abacavir—Hypotension—Valproic Acid—epilepsy syndrome	6.71e-05	0.000363	CcSEcCtD
Abacavir—Asthenia—Carbamazepine—epilepsy syndrome	6.71e-05	0.000363	CcSEcCtD
Abacavir—Diarrhoea—Phenytoin—epilepsy syndrome	6.7e-05	0.000362	CcSEcCtD
Abacavir—Discomfort—Pregabalin—epilepsy syndrome	6.69e-05	0.000362	CcSEcCtD
Abacavir—Nausea—Fosphenytoin—epilepsy syndrome	6.68e-05	0.000361	CcSEcCtD
Abacavir—Diarrhoea—Oxcarbazepine—epilepsy syndrome	6.67e-05	0.00036	CcSEcCtD
Abacavir—Erythema multiforme—Topiramate—epilepsy syndrome	6.66e-05	0.00036	CcSEcCtD
Abacavir—Hypersensitivity—Lamotrigine—epilepsy syndrome	6.66e-05	0.00036	CcSEcCtD
Abacavir—Vomiting—Felbamate—epilepsy syndrome	6.65e-05	0.000359	CcSEcCtD
Abacavir—Pruritus—Carbamazepine—epilepsy syndrome	6.61e-05	0.000358	CcSEcCtD
Abacavir—Rash—Felbamate—epilepsy syndrome	6.59e-05	0.000356	CcSEcCtD
Abacavir—Dermatitis—Felbamate—epilepsy syndrome	6.58e-05	0.000356	CcSEcCtD
Abacavir—Malaise—Gabapentin—epilepsy syndrome	6.58e-05	0.000356	CcSEcCtD
Abacavir—Vertigo—Gabapentin—epilepsy syndrome	6.55e-05	0.000354	CcSEcCtD
Abacavir—Headache—Felbamate—epilepsy syndrome	6.55e-05	0.000354	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Valproic Acid—epilepsy syndrome	6.54e-05	0.000354	CcSEcCtD
Abacavir—Leukopenia—Gabapentin—epilepsy syndrome	6.53e-05	0.000353	CcSEcCtD
Abacavir—Dizziness—Clonazepam—epilepsy syndrome	6.52e-05	0.000352	CcSEcCtD
Abacavir—Nausea—Vigabatrin—epilepsy syndrome	6.52e-05	0.000352	CcSEcCtD
Abacavir—Vomiting—Zonisamide—epilepsy syndrome	6.5e-05	0.000352	CcSEcCtD
Abacavir—Insomnia—Valproic Acid—epilepsy syndrome	6.49e-05	0.000351	CcSEcCtD
Abacavir—Anaphylactic shock—Pregabalin—epilepsy syndrome	6.49e-05	0.000351	CcSEcCtD
Abacavir—Oedema—Pregabalin—epilepsy syndrome	6.49e-05	0.000351	CcSEcCtD
Abacavir—ADK—Metabolism—ABCG2—epilepsy syndrome	6.49e-05	0.00108	CbGpPWpGaD
Abacavir—Asthenia—Lamotrigine—epilepsy syndrome	6.48e-05	0.00035	CcSEcCtD
Abacavir—Dizziness—Phenytoin—epilepsy syndrome	6.48e-05	0.00035	CcSEcCtD
Abacavir—Rash—Zonisamide—epilepsy syndrome	6.45e-05	0.000349	CcSEcCtD
Abacavir—Infection—Pregabalin—epilepsy syndrome	6.45e-05	0.000349	CcSEcCtD
Abacavir—Paraesthesia—Valproic Acid—epilepsy syndrome	6.45e-05	0.000348	CcSEcCtD
Abacavir—Dermatitis—Zonisamide—epilepsy syndrome	6.44e-05	0.000348	CcSEcCtD
Abacavir—Dizziness—Oxcarbazepine—epilepsy syndrome	6.44e-05	0.000348	CcSEcCtD
Abacavir—Nausea—Diazepam—epilepsy syndrome	6.41e-05	0.000347	CcSEcCtD
Abacavir—Headache—Zonisamide—epilepsy syndrome	6.41e-05	0.000346	CcSEcCtD
Abacavir—Dyspnoea—Valproic Acid—epilepsy syndrome	6.4e-05	0.000346	CcSEcCtD
Abacavir—Diarrhoea—Carbamazepine—epilepsy syndrome	6.4e-05	0.000346	CcSEcCtD
Abacavir—Pruritus—Lamotrigine—epilepsy syndrome	6.39e-05	0.000346	CcSEcCtD
Abacavir—Immune system disorder—Topiramate—epilepsy syndrome	6.37e-05	0.000344	CcSEcCtD
Abacavir—Nervous system disorder—Pregabalin—epilepsy syndrome	6.37e-05	0.000344	CcSEcCtD
Abacavir—Cough—Gabapentin—epilepsy syndrome	6.36e-05	0.000344	CcSEcCtD
Abacavir—Thrombocytopenia—Pregabalin—epilepsy syndrome	6.36e-05	0.000344	CcSEcCtD
Abacavir—Chills—Topiramate—epilepsy syndrome	6.32e-05	0.000342	CcSEcCtD
Abacavir—ADK—Metabolism—CYP2C19—epilepsy syndrome	6.32e-05	0.00105	CbGpPWpGaD
Abacavir—Convulsion—Gabapentin—epilepsy syndrome	6.32e-05	0.000342	CcSEcCtD
Abacavir—Skin disorder—Pregabalin—epilepsy syndrome	6.3e-05	0.000341	CcSEcCtD
Abacavir—ADK—Metabolism—CYP11A1—epilepsy syndrome	6.28e-05	0.00104	CbGpPWpGaD
Abacavir—Vomiting—Clonazepam—epilepsy syndrome	6.27e-05	0.000339	CcSEcCtD
Abacavir—Decreased appetite—Valproic Acid—epilepsy syndrome	6.24e-05	0.000337	CcSEcCtD
Abacavir—Alopecia—Topiramate—epilepsy syndrome	6.23e-05	0.000337	CcSEcCtD
Abacavir—Vomiting—Phenytoin—epilepsy syndrome	6.23e-05	0.000337	CcSEcCtD
Abacavir—Rash—Clonazepam—epilepsy syndrome	6.22e-05	0.000336	CcSEcCtD
Abacavir—Dermatitis—Clonazepam—epilepsy syndrome	6.21e-05	0.000336	CcSEcCtD
Abacavir—Myalgia—Gabapentin—epilepsy syndrome	6.21e-05	0.000336	CcSEcCtD
Abacavir—Arthralgia—Gabapentin—epilepsy syndrome	6.21e-05	0.000336	CcSEcCtD
Abacavir—Nausea—Felbamate—epilepsy syndrome	6.21e-05	0.000336	CcSEcCtD
Abacavir—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	6.2e-05	0.000335	CcSEcCtD
Abacavir—Vomiting—Oxcarbazepine—epilepsy syndrome	6.19e-05	0.000335	CcSEcCtD
Abacavir—Fatigue—Valproic Acid—epilepsy syndrome	6.19e-05	0.000335	CcSEcCtD
Abacavir—Anxiety—Gabapentin—epilepsy syndrome	6.19e-05	0.000334	CcSEcCtD
Abacavir—Anorexia—Pregabalin—epilepsy syndrome	6.19e-05	0.000334	CcSEcCtD
Abacavir—Dizziness—Carbamazepine—epilepsy syndrome	6.18e-05	0.000334	CcSEcCtD
Abacavir—Diarrhoea—Lamotrigine—epilepsy syndrome	6.18e-05	0.000334	CcSEcCtD
Abacavir—ADH6—Metabolism—AGT—epilepsy syndrome	6.18e-05	0.00103	CbGpPWpGaD
Abacavir—Headache—Clonazepam—epilepsy syndrome	6.18e-05	0.000334	CcSEcCtD
Abacavir—Rash—Phenytoin—epilepsy syndrome	6.18e-05	0.000334	CcSEcCtD
Abacavir—Dermatitis—Phenytoin—epilepsy syndrome	6.17e-05	0.000333	CcSEcCtD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	6.17e-05	0.000333	CcSEcCtD
Abacavir—Rash—Oxcarbazepine—epilepsy syndrome	6.14e-05	0.000332	CcSEcCtD
Abacavir—Pain—Valproic Acid—epilepsy syndrome	6.14e-05	0.000332	CcSEcCtD
Abacavir—Dermatitis—Oxcarbazepine—epilepsy syndrome	6.14e-05	0.000332	CcSEcCtD
Abacavir—Headache—Phenytoin—epilepsy syndrome	6.14e-05	0.000332	CcSEcCtD
Abacavir—Malnutrition—Topiramate—epilepsy syndrome	6.14e-05	0.000332	CcSEcCtD
Abacavir—Discomfort—Gabapentin—epilepsy syndrome	6.13e-05	0.000332	CcSEcCtD
Abacavir—Headache—Oxcarbazepine—epilepsy syndrome	6.1e-05	0.00033	CcSEcCtD
Abacavir—Nausea—Zonisamide—epilepsy syndrome	6.08e-05	0.000328	CcSEcCtD
Abacavir—Hypotension—Pregabalin—epilepsy syndrome	6.07e-05	0.000328	CcSEcCtD
Abacavir—ADH6—Metabolism—APOE—epilepsy syndrome	6.06e-05	0.00101	CbGpPWpGaD
Abacavir—Dizziness—Lamotrigine—epilepsy syndrome	5.97e-05	0.000323	CcSEcCtD
Abacavir—Oedema—Gabapentin—epilepsy syndrome	5.95e-05	0.000322	CcSEcCtD
Abacavir—Anaphylactic shock—Gabapentin—epilepsy syndrome	5.95e-05	0.000322	CcSEcCtD
Abacavir—Vomiting—Carbamazepine—epilepsy syndrome	5.94e-05	0.000321	CcSEcCtD
Abacavir—Feeling abnormal—Valproic Acid—epilepsy syndrome	5.92e-05	0.00032	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Pregabalin—epilepsy syndrome	5.91e-05	0.00032	CcSEcCtD
Abacavir—Infection—Gabapentin—epilepsy syndrome	5.91e-05	0.00032	CcSEcCtD
Abacavir—Rash—Carbamazepine—epilepsy syndrome	5.89e-05	0.000319	CcSEcCtD
Abacavir—Dermatitis—Carbamazepine—epilepsy syndrome	5.89e-05	0.000318	CcSEcCtD
Abacavir—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	5.87e-05	0.000317	CcSEcCtD
Abacavir—Insomnia—Pregabalin—epilepsy syndrome	5.87e-05	0.000317	CcSEcCtD
Abacavir—Nausea—Clonazepam—epilepsy syndrome	5.86e-05	0.000317	CcSEcCtD
Abacavir—Headache—Carbamazepine—epilepsy syndrome	5.86e-05	0.000317	CcSEcCtD
Abacavir—Nervous system disorder—Gabapentin—epilepsy syndrome	5.84e-05	0.000316	CcSEcCtD
Abacavir—Paraesthesia—Pregabalin—epilepsy syndrome	5.83e-05	0.000315	CcSEcCtD
Abacavir—Thrombocytopenia—Gabapentin—epilepsy syndrome	5.83e-05	0.000315	CcSEcCtD
Abacavir—Nausea—Phenytoin—epilepsy syndrome	5.82e-05	0.000314	CcSEcCtD
Abacavir—Dyspnoea—Pregabalin—epilepsy syndrome	5.79e-05	0.000313	CcSEcCtD
Abacavir—Nausea—Oxcarbazepine—epilepsy syndrome	5.79e-05	0.000313	CcSEcCtD
Abacavir—Skin disorder—Gabapentin—epilepsy syndrome	5.78e-05	0.000313	CcSEcCtD
Abacavir—Vomiting—Lamotrigine—epilepsy syndrome	5.74e-05	0.000311	CcSEcCtD
Abacavir—Urticaria—Valproic Acid—epilepsy syndrome	5.7e-05	0.000308	CcSEcCtD
Abacavir—Rash—Lamotrigine—epilepsy syndrome	5.7e-05	0.000308	CcSEcCtD
Abacavir—Ill-defined disorder—Topiramate—epilepsy syndrome	5.69e-05	0.000308	CcSEcCtD
Abacavir—Dermatitis—Lamotrigine—epilepsy syndrome	5.69e-05	0.000308	CcSEcCtD
Abacavir—Abdominal pain—Valproic Acid—epilepsy syndrome	5.68e-05	0.000307	CcSEcCtD
Abacavir—Body temperature increased—Valproic Acid—epilepsy syndrome	5.68e-05	0.000307	CcSEcCtD
Abacavir—Anorexia—Gabapentin—epilepsy syndrome	5.67e-05	0.000307	CcSEcCtD
Abacavir—ADK—Metabolism—CYP2D6—epilepsy syndrome	5.67e-05	0.000941	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—L2HGDH—epilepsy syndrome	5.67e-05	0.000941	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ADK—epilepsy syndrome	5.67e-05	0.000941	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GLUD1—epilepsy syndrome	5.67e-05	0.000941	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CERS1—epilepsy syndrome	5.67e-05	0.000941	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PDXK—epilepsy syndrome	5.67e-05	0.000941	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—FAR1—epilepsy syndrome	5.67e-05	0.000941	CbGpPWpGaD
Abacavir—Anaemia—Topiramate—epilepsy syndrome	5.67e-05	0.000307	CcSEcCtD
Abacavir—Headache—Lamotrigine—epilepsy syndrome	5.66e-05	0.000306	CcSEcCtD
Abacavir—Decreased appetite—Pregabalin—epilepsy syndrome	5.64e-05	0.000305	CcSEcCtD
Abacavir—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	5.6e-05	0.000303	CcSEcCtD
Abacavir—Fatigue—Pregabalin—epilepsy syndrome	5.6e-05	0.000302	CcSEcCtD
Abacavir—Hypotension—Gabapentin—epilepsy syndrome	5.56e-05	0.000301	CcSEcCtD
Abacavir—Nausea—Carbamazepine—epilepsy syndrome	5.55e-05	0.0003	CcSEcCtD
Abacavir—Pain—Pregabalin—epilepsy syndrome	5.55e-05	0.0003	CcSEcCtD
Abacavir—Malaise—Topiramate—epilepsy syndrome	5.53e-05	0.000299	CcSEcCtD
Abacavir—Vertigo—Topiramate—epilepsy syndrome	5.51e-05	0.000298	CcSEcCtD
Abacavir—Leukopenia—Topiramate—epilepsy syndrome	5.49e-05	0.000297	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Gabapentin—epilepsy syndrome	5.42e-05	0.000293	CcSEcCtD
Abacavir—ADK—Metabolism—ADRA2A—epilepsy syndrome	5.4e-05	0.000896	CbGpPWpGaD
Abacavir—Insomnia—Gabapentin—epilepsy syndrome	5.38e-05	0.000291	CcSEcCtD
Abacavir—ADK—Metabolism—BCHE—epilepsy syndrome	5.38e-05	0.000893	CbGpPWpGaD
Abacavir—Nausea—Lamotrigine—epilepsy syndrome	5.37e-05	0.00029	CcSEcCtD
Abacavir—Cough—Topiramate—epilepsy syndrome	5.35e-05	0.000289	CcSEcCtD
Abacavir—Feeling abnormal—Pregabalin—epilepsy syndrome	5.35e-05	0.000289	CcSEcCtD
Abacavir—Paraesthesia—Gabapentin—epilepsy syndrome	5.34e-05	0.000289	CcSEcCtD
Abacavir—Convulsion—Topiramate—epilepsy syndrome	5.32e-05	0.000287	CcSEcCtD
Abacavir—Gastrointestinal pain—Pregabalin—epilepsy syndrome	5.31e-05	0.000287	CcSEcCtD
Abacavir—Dyspnoea—Gabapentin—epilepsy syndrome	5.31e-05	0.000287	CcSEcCtD
Abacavir—Hypersensitivity—Valproic Acid—epilepsy syndrome	5.29e-05	0.000286	CcSEcCtD
Abacavir—Arthralgia—Topiramate—epilepsy syndrome	5.22e-05	0.000282	CcSEcCtD
Abacavir—Myalgia—Topiramate—epilepsy syndrome	5.22e-05	0.000282	CcSEcCtD
Abacavir—Anxiety—Topiramate—epilepsy syndrome	5.21e-05	0.000281	CcSEcCtD
Abacavir—ADH6—Metabolism—POMC—epilepsy syndrome	5.2e-05	0.000864	CbGpPWpGaD
Abacavir—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	5.19e-05	0.00028	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GAMT—epilepsy syndrome	5.19e-05	0.000861	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PNPO—epilepsy syndrome	5.19e-05	0.000861	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—EPM2A—epilepsy syndrome	5.19e-05	0.000861	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NHLRC1—epilepsy syndrome	5.19e-05	0.000861	CbGpPWpGaD
Abacavir—Decreased appetite—Gabapentin—epilepsy syndrome	5.17e-05	0.00028	CcSEcCtD
Abacavir—Discomfort—Topiramate—epilepsy syndrome	5.16e-05	0.000279	CcSEcCtD
Abacavir—Urticaria—Pregabalin—epilepsy syndrome	5.16e-05	0.000279	CcSEcCtD
Abacavir—Asthenia—Valproic Acid—epilepsy syndrome	5.15e-05	0.000278	CcSEcCtD
Abacavir—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	5.14e-05	0.000278	CcSEcCtD
Abacavir—Fatigue—Gabapentin—epilepsy syndrome	5.13e-05	0.000277	CcSEcCtD
Abacavir—Abdominal pain—Pregabalin—epilepsy syndrome	5.13e-05	0.000277	CcSEcCtD
Abacavir—Body temperature increased—Pregabalin—epilepsy syndrome	5.13e-05	0.000277	CcSEcCtD
Abacavir—ADK—Metabolism—SLC2A1—epilepsy syndrome	5.13e-05	0.000851	CbGpPWpGaD
Abacavir—Pain—Gabapentin—epilepsy syndrome	5.09e-05	0.000275	CcSEcCtD
Abacavir—Pruritus—Valproic Acid—epilepsy syndrome	5.08e-05	0.000275	CcSEcCtD
Abacavir—ADK—Metabolism—PLCB1—epilepsy syndrome	5.07e-05	0.000842	CbGpPWpGaD
Abacavir—ADK—Metabolism—TH—epilepsy syndrome	5.05e-05	0.000839	CbGpPWpGaD
Abacavir—Oedema—Topiramate—epilepsy syndrome	5.01e-05	0.000271	CcSEcCtD
Abacavir—Infection—Topiramate—epilepsy syndrome	4.97e-05	0.000269	CcSEcCtD
Abacavir—Diarrhoea—Valproic Acid—epilepsy syndrome	4.91e-05	0.000266	CcSEcCtD
Abacavir—Nervous system disorder—Topiramate—epilepsy syndrome	4.91e-05	0.000265	CcSEcCtD
Abacavir—Feeling abnormal—Gabapentin—epilepsy syndrome	4.9e-05	0.000265	CcSEcCtD
Abacavir—Thrombocytopenia—Topiramate—epilepsy syndrome	4.9e-05	0.000265	CcSEcCtD
Abacavir—Gastrointestinal pain—Gabapentin—epilepsy syndrome	4.87e-05	0.000263	CcSEcCtD
Abacavir—Skin disorder—Topiramate—epilepsy syndrome	4.86e-05	0.000263	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CA4—epilepsy syndrome	4.82e-05	0.000801	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—QDPR—epilepsy syndrome	4.82e-05	0.000801	CbGpPWpGaD
Abacavir—UGT1A1—Biological oxidations—POMC—epilepsy syndrome	4.81e-05	0.000798	CbGpPWpGaD
Abacavir—Hypersensitivity—Pregabalin—epilepsy syndrome	4.78e-05	0.000259	CcSEcCtD
Abacavir—Anorexia—Topiramate—epilepsy syndrome	4.77e-05	0.000258	CcSEcCtD
Abacavir—Dizziness—Valproic Acid—epilepsy syndrome	4.75e-05	0.000257	CcSEcCtD
Abacavir—ADH6—Metabolism—ALB—epilepsy syndrome	4.74e-05	0.000788	CbGpPWpGaD
Abacavir—Urticaria—Gabapentin—epilepsy syndrome	4.73e-05	0.000256	CcSEcCtD
Abacavir—Body temperature increased—Gabapentin—epilepsy syndrome	4.71e-05	0.000254	CcSEcCtD
Abacavir—Abdominal pain—Gabapentin—epilepsy syndrome	4.71e-05	0.000254	CcSEcCtD
Abacavir—Hypotension—Topiramate—epilepsy syndrome	4.68e-05	0.000253	CcSEcCtD
Abacavir—Asthenia—Pregabalin—epilepsy syndrome	4.66e-05	0.000252	CcSEcCtD
Abacavir—Pruritus—Pregabalin—epilepsy syndrome	4.59e-05	0.000248	CcSEcCtD
Abacavir—Vomiting—Valproic Acid—epilepsy syndrome	4.57e-05	0.000247	CcSEcCtD
Abacavir—Musculoskeletal discomfort—Topiramate—epilepsy syndrome	4.56e-05	0.000247	CcSEcCtD
Abacavir—UGT1A1—Metabolism—COX3—epilepsy syndrome	4.53e-05	0.000753	CbGpPWpGaD
Abacavir—Insomnia—Topiramate—epilepsy syndrome	4.53e-05	0.000245	CcSEcCtD
Abacavir—Rash—Valproic Acid—epilepsy syndrome	4.53e-05	0.000245	CcSEcCtD
Abacavir—Dermatitis—Valproic Acid—epilepsy syndrome	4.52e-05	0.000244	CcSEcCtD
Abacavir—Headache—Valproic Acid—epilepsy syndrome	4.5e-05	0.000243	CcSEcCtD
Abacavir—Paraesthesia—Topiramate—epilepsy syndrome	4.5e-05	0.000243	CcSEcCtD
Abacavir—Dyspnoea—Topiramate—epilepsy syndrome	4.46e-05	0.000241	CcSEcCtD
Abacavir—Diarrhoea—Pregabalin—epilepsy syndrome	4.44e-05	0.00024	CcSEcCtD
Abacavir—Hypersensitivity—Gabapentin—epilepsy syndrome	4.39e-05	0.000237	CcSEcCtD
Abacavir—Decreased appetite—Topiramate—epilepsy syndrome	4.35e-05	0.000235	CcSEcCtD
Abacavir—Gastrointestinal disorder—Topiramate—epilepsy syndrome	4.32e-05	0.000234	CcSEcCtD
Abacavir—Fatigue—Topiramate—epilepsy syndrome	4.32e-05	0.000233	CcSEcCtD
Abacavir—UGT1A1—Metabolism—KCNB1—epilepsy syndrome	4.3e-05	0.000714	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SLCO1A2—epilepsy syndrome	4.3e-05	0.000714	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PFKL—epilepsy syndrome	4.3e-05	0.000714	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CACNA2D2—epilepsy syndrome	4.3e-05	0.000714	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SLC6A8—epilepsy syndrome	4.3e-05	0.000714	CbGpPWpGaD
Abacavir—Dizziness—Pregabalin—epilepsy syndrome	4.29e-05	0.000232	CcSEcCtD
Abacavir—Pain—Topiramate—epilepsy syndrome	4.28e-05	0.000231	CcSEcCtD
Abacavir—Asthenia—Gabapentin—epilepsy syndrome	4.27e-05	0.000231	CcSEcCtD
Abacavir—Nausea—Valproic Acid—epilepsy syndrome	4.26e-05	0.000231	CcSEcCtD
Abacavir—ADK—Metabolism—HMOX1—epilepsy syndrome	4.22e-05	0.0007	CbGpPWpGaD
Abacavir—Pruritus—Gabapentin—epilepsy syndrome	4.21e-05	0.000228	CcSEcCtD
Abacavir—ADK—Metabolism—CAT—epilepsy syndrome	4.16e-05	0.000691	CbGpPWpGaD
Abacavir—ADH6—Metabolism—PTGS2—epilepsy syndrome	4.15e-05	0.000689	CbGpPWpGaD
Abacavir—Vomiting—Pregabalin—epilepsy syndrome	4.13e-05	0.000223	CcSEcCtD
Abacavir—Feeling abnormal—Topiramate—epilepsy syndrome	4.13e-05	0.000223	CcSEcCtD
Abacavir—Gastrointestinal pain—Topiramate—epilepsy syndrome	4.09e-05	0.000221	CcSEcCtD
Abacavir—Rash—Pregabalin—epilepsy syndrome	4.09e-05	0.000221	CcSEcCtD
Abacavir—Dermatitis—Pregabalin—epilepsy syndrome	4.09e-05	0.000221	CcSEcCtD
Abacavir—Diarrhoea—Gabapentin—epilepsy syndrome	4.07e-05	0.00022	CcSEcCtD
Abacavir—Headache—Pregabalin—epilepsy syndrome	4.07e-05	0.00022	CcSEcCtD
Abacavir—ADK—Metabolism—ABCB1—epilepsy syndrome	4.05e-05	0.000672	CbGpPWpGaD
Abacavir—Urticaria—Topiramate—epilepsy syndrome	3.98e-05	0.000215	CcSEcCtD
Abacavir—Abdominal pain—Topiramate—epilepsy syndrome	3.96e-05	0.000214	CcSEcCtD
Abacavir—Body temperature increased—Topiramate—epilepsy syndrome	3.96e-05	0.000214	CcSEcCtD
Abacavir—Dizziness—Gabapentin—epilepsy syndrome	3.94e-05	0.000213	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ATIC—epilepsy syndrome	3.93e-05	0.000653	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NEU1—epilepsy syndrome	3.93e-05	0.000653	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—UPB1—epilepsy syndrome	3.93e-05	0.000653	CbGpPWpGaD
Abacavir—Nausea—Pregabalin—epilepsy syndrome	3.86e-05	0.000208	CcSEcCtD
Abacavir—Vomiting—Gabapentin—epilepsy syndrome	3.78e-05	0.000205	CcSEcCtD
Abacavir—UGT1A1—Metabolism—HSD17B4—epilepsy syndrome	3.78e-05	0.000628	CbGpPWpGaD
Abacavir—ADK—Metabolism—GPX1—epilepsy syndrome	3.76e-05	0.000625	CbGpPWpGaD
Abacavir—Rash—Gabapentin—epilepsy syndrome	3.75e-05	0.000203	CcSEcCtD
Abacavir—Dermatitis—Gabapentin—epilepsy syndrome	3.75e-05	0.000203	CcSEcCtD
Abacavir—Headache—Gabapentin—epilepsy syndrome	3.73e-05	0.000202	CcSEcCtD
Abacavir—Hypersensitivity—Topiramate—epilepsy syndrome	3.69e-05	0.000199	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GBE1—epilepsy syndrome	3.65e-05	0.000607	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PPP1R3C—epilepsy syndrome	3.65e-05	0.000607	CbGpPWpGaD
Abacavir—Asthenia—Topiramate—epilepsy syndrome	3.59e-05	0.000194	CcSEcCtD
Abacavir—Pruritus—Topiramate—epilepsy syndrome	3.54e-05	0.000192	CcSEcCtD
Abacavir—Nausea—Gabapentin—epilepsy syndrome	3.54e-05	0.000191	CcSEcCtD
Abacavir—UGT1A1—Metabolism—ASAH1—epilepsy syndrome	3.44e-05	0.00057	CbGpPWpGaD
Abacavir—Diarrhoea—Topiramate—epilepsy syndrome	3.43e-05	0.000185	CcSEcCtD
Abacavir—UGT1A1—Metabolism—STXBP1—epilepsy syndrome	3.34e-05	0.000555	CbGpPWpGaD
Abacavir—Dizziness—Topiramate—epilepsy syndrome	3.31e-05	0.000179	CcSEcCtD
Abacavir—ADK—Metabolism—AGT—epilepsy syndrome	3.3e-05	0.000548	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—NT5E—epilepsy syndrome	3.26e-05	0.000541	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALAD—epilepsy syndrome	3.26e-05	0.000541	CbGpPWpGaD
Abacavir—ADK—Metabolism—APOE—epilepsy syndrome	3.23e-05	0.000537	CbGpPWpGaD
Abacavir—Vomiting—Topiramate—epilepsy syndrome	3.18e-05	0.000172	CcSEcCtD
Abacavir—Rash—Topiramate—epilepsy syndrome	3.16e-05	0.000171	CcSEcCtD
Abacavir—Dermatitis—Topiramate—epilepsy syndrome	3.15e-05	0.000171	CcSEcCtD
Abacavir—Headache—Topiramate—epilepsy syndrome	3.14e-05	0.00017	CcSEcCtD
Abacavir—UGT1A1—Metabolism—CACNA1A—epilepsy syndrome	3.11e-05	0.000516	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALDH7A1—epilepsy syndrome	3.11e-05	0.000516	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ST3GAL3—epilepsy syndrome	3.04e-05	0.000505	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ADSL—epilepsy syndrome	2.98e-05	0.000495	CbGpPWpGaD
Abacavir—Nausea—Topiramate—epilepsy syndrome	2.97e-05	0.000161	CcSEcCtD
Abacavir—UGT1A1—Metabolism—GLUL—epilepsy syndrome	2.92e-05	0.000485	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CACNA1D—epilepsy syndrome	2.87e-05	0.000476	CbGpPWpGaD
Abacavir—ADK—Metabolism—POMC—epilepsy syndrome	2.78e-05	0.000461	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—TXNRD1—epilepsy syndrome	2.68e-05	0.000445	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AQP1—epilepsy syndrome	2.6e-05	0.000432	CbGpPWpGaD
Abacavir—ADK—Metabolism—ALB—epilepsy syndrome	2.53e-05	0.000421	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—KCNJ11—epilepsy syndrome	2.35e-05	0.000391	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CHRM3—epilepsy syndrome	2.35e-05	0.000391	CbGpPWpGaD
Abacavir—ADK—Metabolism—PTGS2—epilepsy syndrome	2.22e-05	0.000368	CbGpPWpGaD
Abacavir—ADH6—Metabolism—AKT1—epilepsy syndrome	2.09e-05	0.000346	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCG2—epilepsy syndrome	1.92e-05	0.000319	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP2C19—epilepsy syndrome	1.87e-05	0.000311	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP11A1—epilepsy syndrome	1.86e-05	0.000309	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CYP2D6—epilepsy syndrome	1.68e-05	0.000279	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ADRA2A—epilepsy syndrome	1.6e-05	0.000265	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—BCHE—epilepsy syndrome	1.59e-05	0.000264	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—SLC2A1—epilepsy syndrome	1.52e-05	0.000252	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PLCB1—epilepsy syndrome	1.5e-05	0.000249	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—TH—epilepsy syndrome	1.5e-05	0.000248	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—HMOX1—epilepsy syndrome	1.25e-05	0.000207	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—CAT—epilepsy syndrome	1.23e-05	0.000204	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ABCB1—epilepsy syndrome	1.2e-05	0.000199	CbGpPWpGaD
Abacavir—ADK—Metabolism—AKT1—epilepsy syndrome	1.11e-05	0.000185	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—GPX1—epilepsy syndrome	1.11e-05	0.000185	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AGT—epilepsy syndrome	9.77e-06	0.000162	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—APOE—epilepsy syndrome	9.57e-06	0.000159	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—POMC—epilepsy syndrome	8.22e-06	0.000136	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—ALB—epilepsy syndrome	7.5e-06	0.000124	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—PTGS2—epilepsy syndrome	6.56e-06	0.000109	CbGpPWpGaD
Abacavir—UGT1A1—Metabolism—AKT1—epilepsy syndrome	3.3e-06	5.47e-05	CbGpPWpGaD
